Ozempic price without insurance
Ozempic contains semaglutide and is made by Novo Nordisk. Its lowest current self-pay price is $149/30 days for the tablet, across 2 sourced offers. Prices below are by form and dose, each with its seller, conditions and check date.
Ozempic injection
Once weekly
Advertised entry price
$199/fill initially≈ $213.21 per 30 days at this quoted rate
Offer through
Checked
Ozempic pen
NovoCare (Novo Nordisk) · Manufacturer direct
first two monthly fills at 0.25 or 0.5 mg for new patients, prescribed by Dec 31, 2026
Price conditions
first two monthly fills at 0.25 or 0.5 mg for new patients, prescribed by Dec 31, 2026
After the introductory offer: $349 per monthly fill for 0.25, 0.5, or 1 mg; $499 for 2 mg. NovoCare defines one injection fill as a 28-day supply. Eligibility and restrictions apply.
28-day supply
Published maintenance dose
$499/28 days≈ $534.64 per 30 days at this quoted rate
Checked
At 2 mg
Ozempic pen
NovoCare (Novo Nordisk) · Manufacturer direct
Published price at 2 mg
Price conditions
Published price at 2 mg
After the introductory offer: $349 per monthly fill for 0.25, 0.5, or 1 mg; $499 for 2 mg. NovoCare defines one injection fill as a 28-day supply. Eligibility and restrictions apply.
28-day supply
Ozempic tablet
Once daily, on an empty stomach
Advertised entry price
$149/30 days$149 per 30 days at this quoted rate
Checked
Ozempic tablets
NovoCare (Novo Nordisk) · Manufacturer direct
self-pay, 1.5 mg starting dose
Price conditions
self-pay, 1.5 mg starting dose
A prescription is required. The 1.5 mg initiation dose costs $149 for 30 tablets. Self-pay purchases are processed outside insurance and do not count toward deductibles or out-of-pocket limits. Ozempic tablet prices are separate from Wegovy tablet prices.
30-day supply
Every cash quote was checked on or after . Each quote shows its own check date. A quoted dose is not a dosing recommendation. How we source prices
All Ozempic offers
Manufacturer, pharmacy and telehealth quotes for Ozempic itself. Compounded semaglutide is a different, unapproved product and is listed on the main price page.
Some outbound links on GLPcompare are referral links. If you sign up or buy through one, we may earn a commission at no extra cost to you. It never changes the price you pay or the underlying data. Partner status and commission rates contribute to offer and provider value scores and can change their order. Every partner is labeled. Value scores are not medical recommendations; a higher-ranked offer is not necessarily the lowest price or the right product for you.
Compare every GLP-1 priceApproved uses
Eligibility, contraindications and warnings are in the full prescribing information.
Ozempic injection
Adults with type 2 diabetes: glucose control; cardiovascular risk reduction with established cardiovascular disease; kidney and cardiovascular protection with chronic kidney disease.
US prescribing information (Ozempic Injection prescribing information)Reviewed Sep 6, 2026
Ozempic tablet
Adults with type 2 diabetes: glucose control and cardiovascular risk reduction in those at high risk. The tablet label does not include the injection's kidney indication.
US prescribing information (Ozempic Tablet prescribing information)Reviewed Sep 6, 2026
Is Ozempic in shortage?
No shortage is listed in the latest complete FDA check. The FDA does list discontinuation notices for specific presentations. This status covers semaglutide as a whole; last complete check Oct 9, 2026. National reporting does not confirm stock at your pharmacy.
All GLP-1 shortage reportsOzempic cost: common questions
How much does Ozempic cost without insurance?
Injection: $199/fill initially at NovoCare (Novo Nordisk) (≈ $213.21 per 30 days at this quoted rate); $499/28 days at 2 mg. Tablet: $149/30 days at NovoCare (Novo Nordisk) ($149 per 30 days at this quoted rate); $299/30 days at 9 mg. These are self-pay prices from the sellers' own pages, not insurance estimates; the conditions and refill rules listed with each quote apply.
What is Ozempic approved for?
Injection: Adults with type 2 diabetes: glucose control; cardiovascular risk reduction with established cardiovascular disease; kidney and cardiovascular protection with chronic kidney disease. Tablet: Adults with type 2 diabetes: glucose control and cardiovascular risk reduction in those at high risk. The tablet label does not include the injection's kidney indication.